Karo Pharma AB KARBF:Grey Market

RT Quote | Exchange | USD
Last | 07/05/20 EST
6.31UNCH (UNCH)
52 week range
5.40 - 6.31

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.31
  • 52 Week High6.31
  • 52 Week High Date07/06/20
  • 52 Week Low5.40
  • 52 Week Low Date04/14/20
  • Market Cap1,338.49M
  • Shares Out222.57M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.05
  • P/E (TTM)140.09
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Karo Pharma AB News

There is no recent news for this security.

Latest KARBF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Karo Pharma AB, formerly known as Karo Bio AB, is a Sweden-based biopharmaceutical company engaged in the research and development of drugs based on the nuclear receptors. The Company’s pipeline comprises three projects: Estrogen Receptor Beta (ERbeta) cancer, a platform, which focuses on the development of ERbeta in cancer treatment; ERbeta multiple sclerosis (MS), which specializes in the autoimmune disease MS treatment; and Related Orphan Receptor Gamma (RORgamma), which...
Bo Hansen M.D. Ph.D.
Chairman
Christoffer Lorenzen
Chief Executive Officer
Jon Johnsson
Chief Financial Officer
Anna Elmblad
Vice President
Sofia Pedersen
Vice President
Address
Klara Norra Kyrkogata 33
Stockholm
111 22
Sweden